Healthcare > SARS-CoV-2 prophylaxis

Tracking since May 19, 2026 · Latest signal Apr 21, 2026 · 3 matched data points

Overall sentiment

Positive 67% (2)Negative 0% (0)Neutral 33% (1)

Daily sentiment

Claims (1)

Claims contributing to this aggregate. Confirmed negative claims count as negative impact; confirmed positive claims count as positive impact.

The engineered sACE2-Fc fusion protein provides complete prophylactic protection against SARS-CoV-2 through intranasal administration.

Parent: HealthcareEntity: SARS-CoV-2 prophylaxisImpact: positiveDate: Apr 21, 2026Target: The effectiveness of the sACE2-Fc fusion protein as a prophylactic measure against SARS-CoV-2.3 matched entries2 confirmed0 disputed1 neutral0 unclear